Clean Science and Technology Announces Key Leadership Appointments Effective April 1, 2026

2 min read     Updated on 01 Apr 2026, 02:17 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Clean Science and Technology Limited has announced key leadership appointments effective April 1, 2026, following shareholder approvals. The company re-appointed Mr. Krishnakumar Boob as Whole-Time Director for five years, while appointing Mr. Ashok Boob as Executive Vice Chairman and Mr. Siddhartha Sikchi as Managing Director. All appointees are promoter directors with extensive chemical industry experience ranging from two to five decades.

powered bylight_fuzz_icon
36578822

*this image is generated using AI for illustrative purposes only.

Clean science & technology Limited has announced key managerial personnel appointments effective from April 1, 2026, following approvals from shareholders through different governance processes. The specialty chemicals company communicated these leadership changes to stock exchanges under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Leadership Appointments Overview

The company has made three significant appointments to strengthen its executive leadership team:

Position: Name Term Period
Whole-Time Director (Re-appointment) Mr. Krishnakumar Ramnarayan Boob April 1, 2026 to March 31, 2031
Whole Time Director – Executive Vice Chairman Mr. Ashok Ramnarayan Boob April 1, 2026 to July 27, 2027
Managing Director Mr. Siddhartha Ashok Sikchi April 1, 2026 to March 31, 2031

Approval Process and Timeline

The appointments received shareholder approval through established corporate governance processes. Mr. Krishnakumar Boob's re-appointment as Whole-Time Director was approved during the Annual General Meeting held on September 11, 2025, securing his position for a five-year term from April 1, 2026 to March 31, 2031.

The appointments of Mr. Ashok Boob and Mr. Siddhartha Sikchi were approved through Postal Ballot dated December 16, 2025. Mr. Ashok Boob will serve as Whole Time Director – Executive Vice Chairman from April 1, 2026 up to July 27, 2027, while Mr. Siddhartha Sikchi's tenure as Managing Director extends from April 1, 2026 to March 31, 2031.

Executive Profiles and Experience

All three appointees bring substantial industry experience and have been instrumental in the company's development. Mr. Krishnakumar Boob holds a bachelor's degree in pharmacy from the University of Bombay and brings around three decades of chemical industry experience. He previously worked as a director at Mangalam Drugs and Organics Limited and currently holds 2,12,000 equity shares representing 0.20% stake in the company.

Mr. Ashok Boob, who holds a bachelor's degree in chemical engineering from the Institute of Chemical Technology, Mumbai, brings close to 50 years of chemical industry experience. As a career-technocrat and promoter director, he has been instrumental in the company's expansion since inception, holding 36,71,510 equity shares constituting 3.45% of the company.

Mr. Siddhartha Sikchi holds a Master's degree in Science in Organic Chemistry from University of Manitoba, Canada, and a Bachelor's degree in Chemical Technology from Institute of Chemical Technology, Mumbai. With around two decades of specialty chemical industry experience, he holds 57,50,425 equity shares representing 5.41% of the company.

Corporate Governance Roles

The appointees serve on various board committees, enhancing corporate governance structure:

Executive: Committee Memberships
Krishnakumar Boob Corporate Social Responsibility Committee, Finance Committee
Ashok Boob Corporate Social Responsibility Committee, Finance Committee
Siddhartha Sikchi Risk Management Committee, Stakeholders Relationship Committee, Finance Committee

Regulatory Compliance

The company confirmed that all three appointees meet regulatory requirements and are not debarred from holding director positions by SEBI or any other authority, as required under BSE and NSE circulars dated June 20, 2018. The appointments reflect the company's commitment to maintaining experienced leadership while ensuring compliance with corporate governance standards.

Historical Stock Returns for Clean Science & Technology

1 Day5 Days1 Month6 Months1 Year5 Years
-2.52%-1.25%-6.72%-36.89%-43.03%-56.32%

How will the new leadership structure impact Clean Science & Technology's strategic expansion plans in the specialty chemicals sector?

What succession planning challenges might arise given Mr. Ashok Boob's shorter tenure ending in July 2027 compared to other appointees?

Could this management reshuffle signal potential M&A activities or new product line developments in the coming years?

Clean Science & Technology
View Company Insights
View All News
like16
dislike

Clean Science and Technology Allots 800 Equity Shares Under Employee Stock Option Scheme

1 min read     Updated on 17 Mar 2026, 06:07 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Clean Science and Technology Limited allotted 800 equity shares to employees under CSTL ESOS 2021 on 17th March, 2026, at ₹500 per share with ₹499 premium. The allotment increased the company's paid-up share capital from ₹10,62,76,499 to ₹10,62,77,299, with total shares reaching 10,62,77,299. The shares rank pari passu with existing equity shares and are listed on BSE and NSE.

powered bylight_fuzz_icon
35296665

*this image is generated using AI for illustrative purposes only.

Clean Science and Technology Limited has allotted 800 equity shares to eligible employees under its Employee Stock Option Scheme 2021 (CSTL ESOS 2021) on 17th March, 2026. The allotment was approved by the company's Nomination and Remuneration Committee through circular resolution in compliance with SEBI regulations.

Share Allotment Details

The equity shares were issued with specific pricing parameters that reflect the company's current market valuation:

Parameter Details
Number of Shares Allotted 800
Issue Price per Share ₹500
Face Value per Share ₹1
Premium per Share ₹499
Allotment Date 17th March, 2026

Impact on Share Capital

The allotment has resulted in an increase in the company's paid-up share capital structure:

Metric Before Allotment After Allotment
Total Issued Shares 10,62,76,499 10,62,77,299
Paid-up Share Capital ₹10,62,76,499 ₹10,62,77,299

Regulatory Compliance

The allotment was conducted pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has previously received in-principle approvals from both BSE and NSE for its employee stock option scheme:

  • BSE Approvals: 1,00,000 equity shares approved on 9th June, 2022, and 2,50,000 equity shares approved on 25th September, 2023
  • NSE Approvals: 1,00,000 equity shares approved on 16th June, 2022, and 2,50,000 equity shares approved on 25th September, 2023

Share Characteristics

The newly allotted equity shares carry the same rights and privileges as existing shares. All equity shares allotted under the exercise of options rank pari passu with the existing shares of the company. The shares are issued in demat form under ISIN number INE227W01023 and are listed on both BSE (scrip code: 543318) and NSE (trading symbol: CLEAN).

The allotment demonstrates the company's commitment to employee participation in its growth story through structured stock option schemes, providing eligible employees with ownership stakes in the organization.

Historical Stock Returns for Clean Science & Technology

1 Day5 Days1 Month6 Months1 Year5 Years
-2.52%-1.25%-6.72%-36.89%-43.03%-56.32%
Clean Science & Technology
View Company Insights
View All News
like19
dislike

More News on Clean Science & Technology

1 Year Returns:-43.03%